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Abstract
Introduction Systemic inflammatory response syndrome is
common after surgery, and it can be difficult to discriminate
between infection and inflammation. We performed a review of
the literature with the aims of describing the evolution of serum
procalcitonin (PCT) levels after uncomplicated cardiac surgery,
characterising the role of PCT as a tool in discriminating
infection, identifying the relation between PCT, organ failure,
and severity of sepsis syndromes, and assessing the possible
role of PCT in detection of postoperative complications and
mortality.
Methods We performed a search on MEDLINE using the
keyword 'procalcitonin' crossed with 'cardiac surgery,' 'heart,'
'postoperative,' and 'transplantation.' Our search was limited to
human studies published between January 1990 and June
2006.
Results Uncomplicated cardiac surgery induces a
postoperative increase in serum PCT levels. Peak PCT levels
are reached within 24 hours postoperatively and return to
normal levels within the first week. This increase seems to be
dependent on the surgical procedure and on intraoperative
events. Although PCT values reported in infected patients are
generally higher than in non-infected patients after cardiac
surgery, the cutoff point for discriminating infection ranges from
1 to 5 ng/ml, and the dynamics of PCT levels over time may be
more important than absolute values. PCT is superior to C-
reactive protein in discriminating infections in this setting. PCT
levels are higher with increased severity of sepsis and the
presence of organ dysfunction/failure and in patients with a poor
outcome or in those who develop postoperative complications.
PCT levels typically remain unchanged after acute rejection but
increase markedly after bacterial and fungal infections. Systemic
infections are associated with greater PCT elevation than is
local infection. Viral infections are difficult to identify based on
PCT measurements.
Conclusion The dynamics of PCT levels, rather than absolute
values, could be important in identifying patients with infectious
complications after cardiac surgery. PCT is useful in
differentiating acute graft rejection after heart and/or lung
transplantation from bacterial and fungal infections. Further
studies are needed to define cutoff points and to incorporate
PCT levels in useful prediction models.
Introduction
Procalcitonin (PCT) is a polypeptide consisting of 116 amino
acids and is the precursor of calcitonin [1]. The role of PCT in
inflammatory conditions, such as sepsis, was first described
by Assicot et al. [2], who observed a rise in serum PCT levels
three to four hours after a single injection of endotoxin, reach-
ing a maximum 24 hours thereafter [3]. The origin of PCT in the
inflammatory response is not yet fully understood, but it is
believed that PCT is produced in the liver [4] and peripheral
mononuclear cells [5], modulated by cytokines and lipopoly-
saccharide.
Over the last decade, PCT has become increasingly popular
as a novel marker of infection in the intensive care unit (ICU)
setting. Several studies have underscored its value in a variety
of clinical conditions for identifying infectious processes [6-8],
APACHE = acute physiology and chronic health evaluation; CABG = coronary artery bypass graft; CPB = cardiopulmonary bypass; CRP = C-reactive 
protein; CV = coefficient of variation; ICU = intensive care unit; IL-6 = interleukin-6; MIDCAB = minimally invasive direct coronary artery bypass; 
MODS = multiple organ dysfunction syndrome; OPCAB = off-pump coronary artery bypass; PCT = procalcitonin; ROC = receiver operating char-
acteristic; SIRS = systemic inflammatory response syndrome; SOFA = sequential organ failure assessment; WBC = white blood cell.Critical Care    Vol 10 No 5    Sponholz et al.
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characterising the severity of the underlying illness [9,10],
guiding therapy [11-13], and risk stratification [14-16]. Three
different kits for PCT measurement are currently available: the
LUMI-Test, the Q-Test, and the Kryptor Test (BRAHMS AG,
Hennigsdorf, Germany). The most commonly used kit for
measuring PCT, the LUMI-Test, is based on a immunolumino-
metric assay that binds PCT to two different antibodies in the
calcitonin and katacalcin regions of the protein. Results of the
measurement are available within one hour, and only 20 μl of
blood serum or plasma is needed for the test. The sensitivity of
the LUMI-Test is 0.1 ng/ml [17], the functional assay sensitivity
(defined as the smallest value with an interassay precision of
20% coefficient of variation [CV]) is 0.3 ng/ml, and the inte-
rassay precision in the clinically relevant range is between 6%
and 10% CV (data provided by BRAHMS AG). The PCT Q-
Test uses a semiquantitative one-step, solid-phase immu-
noassay that needs 200 μl of serum or plasma, with results
available within 30 minutes. The semiquantitative measure-
ment of the test is correlated to three reference concentrations
of 0.5, 2, and 10 ng/ml [18,19]. The Kryptor Test for PCT
measurement was introduced in 2004. This test is based on
TRACE (time-resolved amplified cryptate emission) technol-
ogy. PCT values are available within 20 minutes with a func-
tional assay sensitivity of 0.06 ng/ml, and 50 μl of blood serum
or plasma is needed for measurement [20]. At a concentration
between 0.1 and 0.3 ng/ml, the Kryptor Test has an intra-assay
CV of less than or equal to 7% and an interassay CV of less
than or equal to 10%, and at concentrations greater than 0.3
ng/ml the intra-assay CV is less than or equal to 3% and the
interassay CV is less than or equal to 6% (data provided by
BRAHMS AG).
Surgical patients, especially those admitted to the ICU after
cardiac surgery, represent a major diagnostic challenge in
terms of identification of infectious complications. These
patients have usually been subjected to intraoperative proce-
dures that may induce various degrees of tissue inflammation
and cytokine liberation [21]. Meisner et al. [22] reported that
PCT concentrations were moderately increased above the
normal range in 32% of patients after minor and aseptic sur-
gery, in 59% after cardiac and thoracic surgery, and in 95% of
patients after surgery of the intestine. Cardiac surgery per se
and the use of cardiopulmonary bypass (CPB) lead to a more
pronounced activation of cytokines than that following some
other surgical procedures [23]. This cytokine 'burst' leads to a
systemic response by the body's inflammatory system, well
known as the systemic inflammatory response syndrome
(SIRS) [24] and similar to that observed with infections, mak-
ing the diagnosis of infection more difficult. Because timing is
crucial in initiating therapy and determining the subsequent
outcome of septic conditions [25], understanding the kinetics
of PCT in various clinical conditions may improve our ability to
use this marker as an early diagnostic tool.
The aims of this qualitative review were, therefore, to identify
the time course of serum PCT levels after uncomplicated car-
diac surgery, to characterise the possible differences in serum
PCT levels with various surgical procedures, and to investi-
gate the value of PCT levels in terms of diagnosing infection or
predicting outcome in these patients.
Materials and methods
We performed a search on MEDLINE using the keyword 'pro-
calcitonin' crossed with 'cardiac surgery,' 'heart,' 'postopera-
tive,' and 'transplantation.' Our search was limited to human
studies published between January 1990 and June 2006. The
abstracts of all articles were used to confirm our target popu-
lation (patients undergoing cardiac surgery), and the corre-
sponding full-text articles were reviewed for the presence of
data with postoperative PCT levels. Two investigators (CS and
YS) independently identified the eligible literature. Among the
pre-defined variables collected were year of publication, study
design (prospective/retrospective/case report), number of
patients included, age group (adults or infants), disease group,
markers other than PCT, and study results. Any inconsisten-
cies between the two investigators in the data collected were
resolved by consensus. To avoid publication bias, abstracts
and full articles were eligible if PCT levels were reported. We
also reviewed the bibliographies of available studies for poten-
tially eligible studies. Of 37 articles that quoted PCT levels in
patients undergoing cardiac surgery, three articles in abstract
form were excluded because of insufficient data [26-28] and
34 were included in our review. Table 1 gives an overview of
the studies included.
Time course of serum PCT levels after uncomplicated 
cardiac surgery
Serum PCT levels increase postoperatively after uncompli-
cated cardiac surgery, reaching a peak level within 24 hours
postoperatively [29-48], and return to normal values in the fol-
lowing days (Figure 1). Peak PCT values, measured by the
immunoluminometric assay, range from 0.5 to 7.0 ng/ml
[29,31-40,42-44,46-48].
Several factors may influence the evolution of serum PCT lev-
els after cardiac surgery in the absence of postoperative com-
plications. The specific surgical techniques used during the
procedure may be one important factor. Franke et al. [34]
reported higher PCT levels in patients after on-pump coronary
artery bypass grafting (CABG) than in those after off-pump
coronary artery bypass (OPCAB) surgery. Kilger et al. [29]
found higher postoperative PCT levels in patients after
OPCAB than in those after minimally invasive direct coronary
artery bypass (MIDCAB), with median PCT levels of 2.0 ng/ml
in the OPCAB and 0.7 ng/ml in the MIDCAB group. PCT lev-
els were also higher after valvular surgery and thoracic aortic
surgery than after CABG, with Loebe et al. [40] reporting PCT
levels of greater than or equal to 5 ng/ml in 13% of patients
who underwent CABG compared with 39% and 35% of thoseC
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Table 1
Studies reporting perioperative PCT levels in patients undergoing cardiac surgery
Reference Year n Age group Disease group PCT assay used and 
other markers
Results
[66] 1997 48 Adults Heart transplantation LUMI-Test PCT levels were elevated after transplantation and decreased in uncomplicated postoperative course.
No PCT elevation was observed with acute graft rejection.
Steroid administration in patients with acute rejection had no influence on PCT levels.
[64]a 1998 78 Adults Heart, lung and heart, and lung 
transplantation
LUMI-Test CRP 
WBC count
PCT levels were similar between patients with acute graft rejection and non-infected patients.
PCT levels were higher in local or systemic infection than rejection.
CRP and WBC count were elevated equally in all groups.
At discharge, PCT was higher in infected than non-infected patients.
At discharge, CRP and WBC count were similar in all groups.
[29] 1998 57 Adults MIDCAB versus CABG, with 
uneventful postoperative course
LUMI-Test CRP 
WBC count
PCT levels were elevated after surgical procedure in both groups and were higher in CABG versus MIDCAB.
CRP levels were similar between CABG and MIDCAB.
WBC count was elevated postoperatively in CABG versus MIDCAB.
[59] 1998 40 Adults CABG with ECC ± aprotinin
CABG with bacterial infection 
CABG with SIRS/no infection
LUMI-Test CRP PCT levels were similar in patients who received aprotinin compared with the control group.
PCT levels were less than 0.5 ng/ml at all time points but were higher in bacterial infection versus SIRS.
CRP levels were similar in bacterial infection and SIRS.
[35] 1999 59 Adults CPB; systemic or local 
infection or control
LUMI-Test CRP PCT levels increased in all groups, peaked at 24 hours, remained high in patients with systemic infection, and 
normalised in others.
CRP levels increased, peaked at 24 to 48 hours, and remained high in all groups; systemic infection > local 
infection > control group.
PCT levels correlated with CRP levels only in infected patients.
PCT: cut-off 4 ng/ml, sensitivity 86%, specificity 98% in predicting infection.
CRP: cut-off 180 mg/l, sensitivity 100%, specificity 75% in predicting infection.
[36] 1999 36 Adults CABG ± CPB; CABG LUMI-Test CRP PCT levels increased in the first 4 days, peaked on day 1, and were higher in patients with SIRS than no-SIRS.
CRP levels peaked on day 1 and remained high through day 8.
After valvular surgery on day 2, CRP levels were similar in patients with SIRS and no-SIRS.
No correlation was observed between PCT levels and duration of CPB, aortic clamping, mechanical ventilation, 
or ICU stay.
No correlation was observed between PCT and CRP levels in no-complication group.
[58]a 2000 78 Adults Heart, lung and heart, and lung 
transplantation
LUMI-Test CRP 
WBC count
PCT levels were higher in systemic than local infection than rejection than no rejection.
PCT levels remained within normal limits in patients with acute graft rejection.
CRP levels were equally elevated in all groups.
WBC count was similar in all groups.
[37] 2000 74 Adults CABG/HTx LUMI-Test CRP 
WBC count ESR
CABG: PCT levels in sepsis > SIRS > no infection.
Patients with no infection had a minimal rise (always less than 0.3 μg/ml) in PCT.
Patients with SIRS also had high PCT levels.
PCT peaked at 24 hours and normalised in 7 days all patients.
HTx: PCT levels were higher in bacterial and fungal infection versus others; CRP was also high in bacterial and 
fungal infections.
[38] 2000 40
0
Adults CPB LUMI-Test CRP 
WBC count
WBC count peaked on day 1 in non-infected patients and on day 2 in infected patients (peak 14,000/μl).
CRP levels peaked on day 2 in both groups and decreased but did not normalise (infection > no infection).
PCT levels peaked on day 1 (infection > no infection) but peaked again on day 6 in infected patients.
[39] 2000 13
1
Adults CPB Postoperative infection 
Septic versus cardiogenic 
shock
LUMI-Test CRP PCT levels peaked on day 1, returned to normal values on day 3, and were higher in infected versus non-infected 
patients.
PCT levels correlated to SAPS II score. PCT in patients with septic shock was always greater than 10 ng/ml.
CRP levels were high in all patients and did not correlate to PCT.
PCT levels were similar in Gram-positive versus Gram-negative infection.
PCT levels were higher in septic versus cardiogenic shock.
PCT: cut-off 1 ng/ml, sensitivity 85%, specificity 95% in predicting infection.
CRP: cut-off 150 mg/l, sensitivity 64%, specificity 84% in predicting infection.C
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[40] 2000 72
2
Adults CPB LUMI-Test CRP 
WBC count
PCT levels increased over the first 24 hours; valvular > aortic > CABG.
PCT levels were greater in non-survivors versus survivors.
[54] 2000 11
0
Adults Cardiac surgery LUMI-Test CRP 
WBC count TTR 
Iron
PCT did not change in patients with uncomplicated postoperative course and was similar in MIDCAB and open 
surgery.
CRP levels peaked on POD 3.
CRP levels were similar in minor and major infected patients.
WBC count peaked on POD 2.
TTR decreased postoperatively, reaching a nadir on PODs 3 and 4.
Iron decreased postoperatively, was at its lowest value on POD 2, and was similar in all groups.
[63] 2000 42 Adults CPB LUMI-Test 
Neopterin NO 
metabolites
PCT levels were higher in complicated than uncomplicated CPB course on PODs 1 and 2.
Neopterin was higher in complicated than uncomplicated CPB course.
NO metabolites were higher in complicated than uncomplicated CPB course during ECC and on POD 1.
PCT cut-off 0.15 ng/ml, positive predictive value 67%, and negative predictive value 82% in predicting 
postoperative complications.
[65] 2001 11
0
Adults Heart, lung, or liver 
transplantation
LUMI-Test SAA 
CRP
PCT levels had higher predictive value for bacterial or fungal infection than SAA or CRP.
Peak PCT, SAA, and CRP levels were higher in bacterial or fungal infection than viral infection or acute rejection.
Peak PCT and SAA levels were slightly higher in patients with viral infection than in those after uneventful 
course.
[49] 2001 37 Children Elective repair of congenital 
heart disease with CPB
LUMI-Test 
Troponin I (TnI) 
CK
TnI and CK were higher in cross-clamping time (CCT) greater than 80 minutes versus less than 80 minutes and 
in ventriculotomy versus atriotomy.
PCT levels were higher in CCT greater than 80 minutes versus less than 80 minutes and in ventriculotomy 
versus atriotomy.
[41] 2001 24 Adults MODS after CPB LUMI-Test CRP 
IL-6 LBP
CRP and LBP levels were similar between study groups irrespective of MODS.
IL-6 levels were higher in MODS than SIRS in the first 4 postoperative days.
PCT levels were higher in patients with MODS than in those with SIRS.
PCT/LPB was higher in patients with MODS with infection than MODS without infection.
[42] 2001 33 Adults Cardiac surgery and 
perioperative myocardial 
infarction (PMI)
LUMI-Test CRP PCT levels started to rise after CPB, peaked within 24 hours postoperatively, and decreased after 48 hours.
CRP levels peaked after 48 hours and remained elevated after 72 hours.
PCT levels were higher in PMI versus no PMI postoperatively and correlated to TnI.
[43] 2002 40 Adults CABG with CPB; dopexamine, 
epidural anaesthesia, or 
control
LUMI-Test CRP 
WBC count TNF 
Human soluble 
ICAM-1
PCT/CRP/WBC count was elevated 4 and 18 hours after CPB.
PCT levels were lower in patients receiving dopexamine and epidural versus control after 4 and 18 hours.
WBC count was lower in dopexamine versus control at 4 hours after CPB.
TNF levels were elevated in control 30 minutes after CPB versus baseline and returned to baseline after 18 
hours.
[50] 2002 20 Children Tetralogy of Fallot (TOF) LUMI-Test CRP 
IL-6 IL-10
IL-6 levels were elevated in TOF versus healthy infants and preoperatively were higher in TOF versus VSD/AVC.
IL-10 levels were lower in TOF versus VSD/AVC preoperatively and during CPB.
CRP levels were lower in TOF versus VSD/AVC 24 hours after CPB.
PCT levels were elevated after CPB in TOF versus VSD/AVC.
[44] 2002 63 Adults CABG surgery with CPB with 
SIRS, severe SIRS, and 
control
LUMI-Test CRP 
WBC count
WBC count was similar between sepsis syndromes.
CRP levels were higher in SIRS and severe SIRS versus control, with no difference between SIRS and severe 
SIRS.
PCT levels were higher postoperatively in severe SIRS versus SIRS/control, with no difference between SIRS 
and no SIRS.
[45] 2002 20
8
Adults Elective cardiovascular surgery LUMI-Test CRP 
Lactate
PCT levels were higher in patients with postoperative complications.
PCT, but not CRP, levels correlated with APACHE, SOFA, lactate, duration of ECC, duration of surgery, and 
ICU stay.
PCT: cut-off 2 ng/ml, sensitivity 83.3%, specificity 75.2% in predicting infections.
[67] 2002 40 Adults ECC + CABG LUMI-Test WBC 
count Elastase AT 
III
PCT levels did not change perioperatively.
[62]a 2003 45
4
Adults CABG LUMI-Test 
Albumin 
Euroscore COD
In multivariate analysis, serum albumin was associated with poorer outcome than PCT.
PCT greater than 2.8 ng/ml discriminated non-survivors.
Table 1 (Continued)
Studies reporting perioperative PCT levels in patients undergoing cardiac surgeryC
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[55] 2003 28 Adults CPB LUMI-Test IL-6, IL-
8, IL-18, IL-10, 
TGF-β
PCT/IL-8/IL-18 levels were higher in non-survivors. (IL-6, IL-10, and TGF-β were not.)
[46] 2003 25 Children CPB LUMI-Test CRP 
IL-6
PCT levels typically peaked at 24 hours and normalised postoperatively after day 5.
CRP levels peaked at day 3 and remained elevated.
IL-6 peaked at 6 hours and remained elevated.
Peak PCT (not CRP/IL-6) levels correlated with duration of CPB, duration of aortic cross-clamping, days of 
intubation, and ICU days. Only PCT levels were higher in complicated cases.
[47]b 2003 5 Adults Aa disc LUMI-Test CRP 
WBC count
PCT levels were higher preoperatively and peaked at 24 hours (likewise CRP).
WBC count continued to rise at 48 hours.
[57] 2003 80 Adults CABG with APACHE II > 20 LUMI-Test PCT was higher in non-survivors than survivors, in infected than non-infected patients, and in complicated than 
uncomplicated cases.
PCT greater than 5 ng/ml had a sensitivity of 81.5% and a specificity of 45.3% in predicting infection.
PCT greater than 10 ng/ml had a sensitivity of 72.2% and a specificity of 51% in discriminating non-survivors.
[68] 2004 63 Adults OPCAB LUMI-Test N-BNP N-BNP/PCT levels were higher in severe SIRS > SIRS > others.
[48]a 2004 37 Children Surgery for congenital heart 
disease
LUMI-Test IL-6 IL-6 levels increased postoperatively 50-fold independent of CCT, peaked within 24 hours after surgery, and 
were similar according to CCT, surgical technique, and CBT over the study period.
PCT levels postoperatively were higher in CCT greater than 80 minutes versus less than 80 minutes, in 
ventriculotomy versus atriotomy, and in CBT below 22°C versus above 22°C.
[32] 2004 14 Children Surgery for congenital heart 
disease with CPB
LUMI-Test CRP PCT levels were higher after CPB than preoperative.
PCT level peaked on POD 1 and decreased on POD 2.
CRP levels were higher after CPB than preoperatively.
CRP levels peaked just after CPB and remained high on POD 3.
[33] 2005 32 Adults Elective CABG LUMI-Test CRP 
WBC count
Baseline PCT levels were similar with uncomplicated and complicated postoperative course but peaked at 48 
hours in complicated cases, reaching higher levels than uncomplicated cases.
CRP/WBC count showed similar kinetics irrespective of the presence of complications.
[34] 2005 10
8
Adults Elective thoracic (TC) and 
cardiac surgery (CABG + 
CPB/OPCAB)
LUMI-Test IL-6 IL-
8 TNF-α CRP LBP 
IL-2R
IL-6 levels increased postoperatively and were similar in all groups.
IL-8 levels increased postoperatively in OPCAB and CABG but not after TC.
TNF levels increased postoperatively in OPCAB and TC but not in CABG.
CRP and LBP levels increased postoperatively and peaked by the third day.
PCT levels peaked after 24 hours and normalised within 5 days but were higher in CABG versus OPCAB.
IL-2R levels increased postoperatively and peaked within 3 days.
[31] 2006 53 Children Elective cardiac surgery ± 
CPB
LUMI-Test PCT levels were higher in POD 1 to POD 3 versus baseline.
No correlation was observed between PCT levels and bypass duration.
In patients with CPB, postoperative PCT values were greater than 1 ng/ml.
In patients without CPB, postoperative PCT was less than 1 ng/ml.
[30] 2006 33 Children Cardiac surgery ± CPB Kryptor CRP 
WBC count
PCT levels were higher in SIRS + organ failure than SIRS alone after surgery. PCT levels peaked on POD 1 and 
decreased until POD 4.
CRP levels were similar between SIRS + organ failure and SIRS alone.
CRP levels peaked on POD 2.
WBC count was similar in SIRS + organ failure and SIRS alone until POD 3, then higher in SIRS + organ failure 
than SIRS alone.
Peak PCT level correlated to ACC, duration of CPB, mechanical ventilation, ICU and hospital stay, mortality, and 
organ failure development.
Peak PCT level of 0.7 ng/ml had a sensitivity of 85% and a specificity of 58% in predicting organ failure.
Peak PCT level of 7.7 ng/ml had a sensitivity of 100% and a specificity of 100% in predicting organ failure.
Peak PCT level of 5 ng/ml had a sensitivity of 100% and a specificity of 65% in predicting mortality.
Peak PCT level of 34.2 ng/ml had a sensitivity of 100% and a specificity of 90% in predicting infection.
aRetrospective study; bcase report. Aa disc, dissection of the aortic artery; APACHE, acute physiology and chronic health evaluation; AT III, antithrombin III; CABG, coronary artery bypass grafting; CBT, 
coronary artery bypass time; CK, creatine kinase; COD, colloid osmotic pressure; CPB, cardiopulmonary bypass; CRP, C-reactive protein; ECC, extracorporeal circulation; ESR, erythrocyte sedimentation 
rate; HTx, heart transplantation; ICAM-1, intercellular adhesion molecule-1; ICU, intensive care unit; IL, interleukin; LPB, lipopolysaccharide binding protein; MIDCAB, minimally invasive coronary artery 
bypass; MODS, multiorgan dysfunction syndrome; N-BNP, pro-brain natriuretic peptide; NO, nitric oxide; OPCAB, off-pump coronary artery bypass; PCT, procalcitonin; POD, postoperative day; SAA, 
serum amyloid A; SAPS, simplified acute physiology score; SIRS, systemic inflammatory response syndrome; SOFA, sequential organ failure assessment; TGF-β, transforming growth factor-beta; TNF, 
tumour necrosis factor; TTR, transthyretin; VSD/AVC, ventricular septal defect/atrioventricular conduit; WBC, white blood cell.
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who underwent valvular and aortic surgery, respectively. A
more pronounced increase in serum PCT levels was also
reported after procedures involving ventriculotomy than after
those involving atriotomy [48,49]. In paediatric patients, PCT
levels increased more markedly after surgical repair of Tetral-
ogy of Fallot than in those undergoing repair of ventricular sep-
tal defect or atrial septal defect [50]. Intraoperative factors
have also been shown to influence the postoperative evolution
of serum PCT levels (for example, aortic cross-clamping time
[30,46,48,49], duration of CPB [30,45,46], and the duration
of surgery [45]).
Elevated PCT levels after surgical procedures may be
explained by normal PCT kinetics. Three to four hours after
injection of endotoxin in healthy subjects, PCT levels start to
rise, reaching a maximum 24 hours thereafter [3]. The return in
PCT levels to normal within a few days after surgery after an
uncomplicated postoperative course can be explained by the
half-life of PCT (18 to 24 hours) [1] in the absence of a further
insult that may induce more PCT production. Meisner et al.
[51] showed that PCT production could be induced by various
stimuli such as trauma, tissue injury, and others and that this
non-specific and non-infectious stimulation of PCT is much
lower than specific induction and much lower compared with
other markers of the inflammatory response. The source of
PCT production in these conditions could be explained by
non-specific cytokine liberation from the injured tissue [52].
Endotoxin release has also been reported after procedures
involving the heart-lung machine [53].
The evolution of other clinically used markers of tissue inflam-
mation/infection in relation to that of PCT was also reported in
some comparative studies. C-reactive protein (CRP) levels
increase postoperatively, peaking between postoperative days
one and three and remaining elevated up to the second week
postoperatively [29,30,35,54]. irrespective of the extent of
surgery [33,34,36,38,42,45,46,54]. Levels of interleukin-6 (IL-
6), another marker of immune system activation, also increase
postoperatively [34,41,46,48,50,55,56]., peaking at 6 to 24
hours after surgery [34,46,48], and are probably not related to
the extent of surgery [48].
In summary, uncomplicated cardiac surgery induces a postop-
erative increase in serum PCT levels. Peak PCT levels are
reached within 24 hours postoperatively and return to normal
levels within the first week. This increase seems to be depend-
ent on the surgical procedure, with more invasive procedures
associated with higher PCT levels, and on intraoperative
events, including aortic cross-clamping time, duration of CPB,
and the duration of surgery.
PCT as a tool for identifying infection
Because of the marked overlap of signs and symptoms, diag-
nosis of infection still represents a major challenge in ICU
patients after cardiac surgery. Early differentiation between
SIRS after cardiac surgery and the development of periopera-
tive infection is crucial to enable appropriate antibiotic therapy
to be started and to prevent subsequent complications.
Several studies reported higher PCT levels after cardiac sur-
gery in infected compared with non-infected patients [33,35-
38,41,45,57,58]. Importantly, PCT levels remained elevated in
the first week postoperatively [35,37,38]. The elevations in
PCT levels were also reported to be more pronounced in bac-
terial and fungal infections than in viral infections of SIRS
[37,59]. PCT levels ranged from a mean value of 4 ng/ml up to
30 ng/ml in infected patients, depending on the time at which
infection was diagnosed. Initiating appropriate antibiotic ther-
apy seems to bring about a marked reduction in PCT levels.
Rothenburger et al. [35] reported a decrease in PCT levels in
patients with systemic infection after cardiac surgery within 5
days after starting appropriate antibiotic therapy (from a
median of 11 to 0.56 ng/ml).
In addition to PCT, CRP levels increase consistently after
infection [35,38,40] and both seem to be correlated to infec-
tion in this subgroup of patients [38]. In contrast to PCT and
CRP, white blood cell (WBC) count has no discriminative
power in differentiating infected from non-infected patients
after cardiac surgery [33,38,54].
Rothenburger et al. [35] evaluated the diagnostic value of PCT
and CRP in a group of 59 patients undergoing CPB. At a cut-
off level of 4 ng/ml, PCT had a sensitivity of 86% and a specif-
icity of 98% in predicting infection, whereas CRP at a cutoff
level of 180 mg/l had a sensitivity of 100% and a specificity of
75%. Likewise, Aouifi et al. [39] reported that PCT was supe-
Figure 1
Serum procalcitonin (PCT) concentrations in patients after cardiac sur- gery with no complications according to the type of surgery Serum procalcitonin (PCT) concentrations in patients after cardiac sur-
gery with no complications according to the type of surgery. Group 1, 
coronary artery bypass grafting (CABG) with cardiopulmonary bypass 
(CPB). Group 2, CABG without CPB. Group 3, valvular surgery with 
CBP.© The Board of Management and Trustees of the British Journal of 
Anaesthesia. Reproduced from [36] by permission of Oxford University 
Press/British Journal of Anaesthesia.Available online http://ccforum.com/content/10/5/R145
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rior to CRP in predicting an infectious aetiology in 131 adult
patients undergoing CPB. At a 1 ng/ml cutoff point, PCT had
a sensitivity of 85% and a specificity of 95% in predicting
infection, whereas CRP had a sensitivity of only 64% and a
specificity of 84% at a cutoff level of 150 mg/l. Moreover, the
area under the receiver operating characteristic (ROC) curves
for prediction of infection was 0.82 and 0.62 for PCT and
CRP, respectively (Figure 2). In addition, in 80 high-risk
patients with an APACHE (acute physiology and chronic
health evaluation) II score of greater than 20 undergoing
CABG, Dörge et al. [57] found that PCT levels greater than 5
ng/ml had a sensitivity of 82% for discrimination of an infec-
tious process but a poor specificity (only 45%). Meisner et al.
[45] investigated the diagnostic value of PCT in predicting
microbiologically proven infection in patients undergoing elec-
tive cardiovascular surgery. PCT levels greater than 2 ng/ml
had a sensitivity of 83% and a specificity of 75% in this
respect.
In summary, PCT values reported in infected patients are gen-
erally higher than in non-infected patients after cardiac sur-
gery. PCT is superior to CRP in discriminating infections in this
setting. PCT levels decrease markedly after initiation of appro-
priate antibiotic therapy. The dynamics of PCT levels, rather
than the absolute values, could be important in identifying
patients with infectious complications after cardiac surgery.
The relation between PCT, organ failure, and severity of 
sepsis syndromes
Several studies have suggested the presence of a correlation
between serum PCT levels, the severity of sepsis syndromes,
and the occurrence of organ dysfunction/failure after cardiac
surgery [36,37,41,44,59]. Aouifi et al. [36] reported that PCT
levels were correlated with the severity of sepsis. PCT levels
reached up to 20 ng/ml in patients with sepsis and were as
high as 97 ng/ml in patients who developed septic shock after
CBP. Sablotzki et al. [41,55] reported an elevation in PCT lev-
els of more than 20 ng/ml during the first 3 days in patients
suffering from multiorgan dysfunction syndrome (MODS) com-
pared with patients with SIRS. Boeken et al. [59] reported
mean PCT levels of 19 ng/ml in patients with sepsis, whereas
sepsis-free patients had a mean PCT value of only 0.8 ng/ml.
Recently, Celebi et al. [30] reported that PCT levels greater
than 0.7 ng/ml, using the Kryptor assay, could predict postop-
erative organ failure in children undergoing cardiac surgery
with a sensitivity of 85% and a specificity of 58%; at a cutoff
level of 7.7 ng/ml, sensitivity and specificity rose to 100%.
Brunkhorst et al. [9] found that PCT levels greater than 2 ng/
ml discriminated patients with severe sepsis but not those with
septic shock.
From the available literature, it is difficult to recommend cutoff
points for discriminating patients according to the presence of
organ dysfunction/failure or the severity of sepsis syndromes
after cardiac surgery. In a group of 101 critically ill patients,
Giamarellos-Bourboulis et al. [60,61] failed to demonstrate
any agreement between standard definitions of sepsis syn-
dromes and those incorporating PCT levels as part of the diag-
nostic criteria.
Comparative data with other markers of tissue inflammation
are scanty. Only two studies reported higher IL-6 levels, equiv-
alent to the increase in PCT, in patients developing MODS on
the first postoperative day compared with patients with SIRS
without evidence of organ failure [41,55], and WBC count
[44] was poorly discriminative in this respect [41,55].
In summary, PCT levels are higher with increased severity of
sepsis syndromes and the presence of organ dysfunction/fail-
ure. Interpretation of PCT levels in this context should take
these factors into consideration. PCT levels are correlated to
the severity of sepsis syndromes; however, it is difficult to rec-
ommend cutoff points from the current literature.
The role of PCT in predicting postoperative 
complications and death
The association between serum PCT levels and the severity of
sepsis syndromes and organ dysfunction/failure has created
interest in the possible prognostic value of PCT levels. PCT
levels have been shown to be correlated to several severity-of-
illness scoring systems used in clinical practice, including
APACHE II [45] and SAPS (simplified acute physiology score)
Figure 2
Procalcitonin (PCT) or C-reactive protein (CRP) to predict infection Procalcitonin (PCT) or C-reactive protein (CRP) to predict infection. 
Receiver operating characteristic (ROC) curve for PCT and CRP val-
ues for prediction of infection. From [39] with permission.Critical Care    Vol 10 No 5    Sponholz et al.
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II [39,45] scores. In addition, PCT levels correlated well with
the degree of organ dysfunction/failure as assessed by the
SOFA (sequential organ failure assessment) score [45]. Meis-
ner et al. [45] showed that PCT levels correlated well to the
maximum values of SOFA score over the first 2 postoperative
days in 208 patients undergoing CPB. Indeed, several studies
[40,41,55,57,62] have reported higher PCT levels in non-sur-
vivors after cardiac surgery compared with survivors. How-
ever, the discriminative power of PCT in this respect has been
less investigated [41,55,57,62]. Dörge et al. [57] found that
PCT levels greater than 10 ng/ml 24 hours postoperatively
could discriminate non-survivors in a high-risk group of
patients after CPB with a sensitivity of 72% but with a low spe-
cificity (51.3%). However, Fritz et al. [62] reported that a PCT
level as low as 2.8 ng/ml was the best cutoff for predicting 28-
day mortality in patients after CABG. Similarly, Celebi et al.
[30] reported predictive values of postoperative PCT for mor-
tality in children undergoing cardiac surgery. At a cutoff level
of 34.2 ng/ml, PCT had a sensitivity of 100% and a specificity
of 90%, whereas at a cutoff level of 5 ng/ml, PCT had a sensi-
tivity of 100% and a specificity of 65% in predicting mortality.
PCT levels were also found to be related to the development
of postoperative complications [42,45,46,57,63]. Lecharny et
al. [42] described higher mean PCT levels in patients who
developed postoperative myocardial infarction than in those
with an uneventful postoperative course. Meisner et al. [45]
demonstrated a correlation between postoperative PCT levels
in terms of the development of SIRS, respiratory failure, and
the need for positive inotropic support. Likewise, Dörge et al.
[57] reported higher PCT levels in patients who developed
postoperative organ failure than in those with an uncompli-
cated postoperative course. Adamik et al. [63] reported that
after CPB, PCT levels remained unchanged in patients with an
uneventful recovery and increased in patients with complica-
tions, especially in those who developed renal and hepatic
dysfunction in addition to respiratory and circulatory insuffi-
ciency. Using a cutoff value of just 2.0 ng/ml, the positive and
negative predictive values for postoperative complications
were 100%/93% and 100%/87% on the first and second
postoperative days, respectively. CRP does not seem to be
useful as a prognostic marker [36], likely due to its prolonged
elevation after an uneventful postoperative course.
In summary, PCT levels are consistently higher in patients with
a poor outcome and in those who develop postoperative com-
plications. Further studies are needed to define cutoff points
and to incorporate PCT levels in useful prediction models.
Role of PCT in monitoring patients after heart 
transplantation
Another potentially useful implication of serum PCT measure-
ment is the differential diagnosis of postoperative complica-
tions in critically ill patients who have undergone heart
transplantation. Differentiation between postoperative infec-
tion and rejection is important in order to be able to initiate
appropriate therapy. Several studies [37,58,64-66] have eval-
uated the role of PCT in patients after heart and/or lung trans-
plantation. In 12 patients undergoing endomyocardial biopsy
after heart transplantation, Boeken et al. [37] described ele-
vated PCT levels in patients with proven bacterial or fungal
infection, whereas patients who developed graft rejection had
almost normal PCT levels. Patients suffering from viral infec-
tions had PCT levels comparable with those with graft rejec-
tion. Hammer et al. [58] reported similar findings in a cohort of
78 patients after heart, lung, or heart and lung transplantation.
CRP levels were equally elevated in all groups. Hammer et al.
[64] also reported higher PCT levels in patients with systemic
infections than in those with local infection after heart and lung
transplantation. PCT levels were almost within normal limits in
patients with acute rejection; CRP levels, however, were simi-
larly elevated in all groups [64].
In summary, PCT is useful in differentiating acute graft rejec-
tion after heart and/or lung transplantation from bacterial and
fungal infections. PCT levels typically remain unchanged after
acute rejection but increase markedly after bacterial and fun-
gal infections. Systemic infections are associated with more
PCT elevation than is local infection. Viral infections are diffi-
cult to identify based on PCT measurements, being only
slightly elevated in these patients. CRP levels do not seem to
be useful in this setting, because they remain equally elevated
regardless of the type of postoperative complication.
Conclusion
The aims of this qualitative review were to describe the evolu-
tion of PCT after cardiac surgery and to assess the value of
PCT in terms of diagnosing infection or predicting outcome in
these patients. From the available literature, it is difficult to rec-
ommend universal cutoff points for PCT which clearly identify
and differentiate a normal from a complicated postoperative
course. PCT levels should be interpreted, therefore, according
to the clinical context. After uncomplicated cardiac surgery,
PCT levels increase to achieve a peak level within 24 hours
postoperatively and return to normal levels within one week
after surgery. The degree of PCT elevation depends on the
intraoperative course and the type of the surgical procedure
but is unlikely to exceed 5 ng/ml. Patients with a complicated
postoperative course, with infection or sepsis syndromes,
show higher PCT levels than patients with an uncomplicated
course. PCT could be useful in differentiating acute graft rejec-
tion of heart and/or lung transplantation from bacterial and fun-
gal, but not from viral, infections.
Concerning the previous limitations and interactions, PCT
kinetics seems to be more attractive in identifying patients with
infectious complications. There is also evidence that the evo-
lution of PCT levels can be helpful in assessing the adequacy
of antibiotic therapy in bacterial infection [12,13].Available online http://ccforum.com/content/10/5/R145
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A meta-analysis by Simon et al. [6] showed that the PCT level
was more sensitive (88% versus 75%) and more specific
(81% versus 67%) than the CRP level in differentiating bacte-
rial from non-infective causes of inflammation. The sensitivity
for differentiating bacterial from viral infections was also higher
for PCT; the specificities were comparable. PCT also had a
higher positive likelihood ratio and lower negative likelihood
ratio than did CRP in both groups. The analysis included pub-
lished studies that evaluated these markers for the diagnosis
of bacterial infections in hospitalised patients. In a more recent
meta-analysis [10] in adults in ICUs or after surgery or trauma,
the summary ROC curve for PCT was better than for CRP.
Unfortunately, only a few studies [30,35,39] have reported
data on the comparative accuracy between these markers in
patients who have undergone cardiac surgery, hindering a
meta-analysis of this group. However, the growing body of evi-
dence suggests a minor role for CRP compared with serum
PCT in identifying infectious complications in this setting. Fur-
ther studies are needed to clarify this issue.
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